# Mifepristone as Adjunctive Therapy in Alzheimer's Disease

> **NCT00105105** · PHASE2 · TERMINATED · sponsor: **Corcept Therapeutics** · enrollment: 160 (—)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Mifepristone

## Key facts

- **NCT ID:** NCT00105105
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-04
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 160 (—)
- **Last updated:** 2009-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00105105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00105105, "Mifepristone as Adjunctive Therapy in Alzheimer's Disease". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00105105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*